Search for: "Anda Pharmaceuticals, Inc" Results 1 - 20 of 562
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Dec 2014, 9:59 pm by Patent Docs
TWI Pharmaceuticals, Inc., where the patentee prevailed only to face almost certain defeat on remand. [read post]
18 Jul 2017, 9:58 pm by Patent Docs
Noonan -- In multiple ANDA litigations against multiple defendants, Millennium Pharmaceuticals, Inc. had several of its asserted claims held invalid for obviousness at the district court. [read post]
8 May 2017, 8:27 pm by Patent Docs
Breckenridge Pharmaceutical, Inc., illustrates the risks a litigant can take when agreeing to stipulation in an effort at least to reduce litigation costs and issues presented at trial. [read post]
6 May 2019, 9:58 pm by Patent Docs
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
20 Aug 2019, 9:59 pm by Patent Docs
Noonan -- Last week, the Federal Circuit reversed findings of non-obviousness and affirmed (over Chief Judge Prost's dissent) a finding that claims asserted in ANDA litigation were not invalid for failure to satisfy the written description requirement in Nalproprion Pharmaceuticals, Inc. v. [read post]
29 Jan 2018, 12:51 pm by Daily Record Staff
Rockville-based CASI Pharmaceuticals Inc., a biopharmaceutical company dedicated to bringing quality pharmaceutical products to the Chinese and U.S. markets, announced Monday it has acquired a portfolio of 25 U.S. [read post]
12 Oct 2010, 9:59 pm by Patent Docs
. ยง 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
7 Apr 2014, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
16 Apr 2012, 9:49 pm by Patent Docs
Sunovion Pharmaceuticals Inc., the Federal Circuit affirmed a District Court's conclusion that it had subject-matter jurisdiction over a declaratory judgment action of a second ANDA filer, and as a result also affirmed the District Court's final judgment of non-infringement (based on a stipulation of the parties). [read post]
14 Oct 2015, 9:59 pm by Patent Docs
Noonan -- Last week the Federal Circuit affirmed a District Court's finding of invalidity and non-infringement in ANDA litigation between Spectrum Pharmaceuticals and Sandoz. [read post]
22 Jan 2007, 6:39 pm
Cir. 2007, 06-1102) Caraco filed an ANDA with the intent to make  and sell a pharmaceutical composition containing tramadol and acetaminophen with an average weight ratio of tramadol to acetaminophen of  1:8.67, and no less than a ratio of  1:7.5. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]